IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,633,528 | -13.4% | 89,278 | 0.0% | 0.50% | -11.3% |
| Q2 2023 | $5,353,109 | -14.2% | 89,278 | -32.0% | 0.56% | -17.7% |
| Q1 2023 | $6,238,806 | -27.1% | 131,288 | -12.5% | 0.68% | -23.3% |
| Q4 2022 | $8,560,500 | -0.1% | 150,000 | 0.0% | 0.89% | -0.4% |
| Q3 2022 | $8,571,000 | +64.1% | 150,000 | +7.1% | 0.90% | +51.3% |
| Q2 2022 | $5,223,000 | +2.5% | 140,000 | -17.9% | 0.59% | +17.9% |
| Q1 2022 | $5,097,000 | +66.1% | 170,472 | +89.4% | 0.50% | +146.6% |
| Q4 2021 | $3,069,000 | -8.0% | 90,000 | 0.0% | 0.20% | -12.8% |
| Q3 2021 | $3,336,000 | -5.1% | 90,000 | 0.0% | 0.23% | -2.1% |
| Q2 2021 | $3,515,000 | – | 90,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |